South Africa and the fight against TB
Tuberculosis remains the world’s deadliest infectious disease, with South Africa experiencing one of the highest burdens but also leading scientific progress in treatment, vaccines, diagnostics and prevention. Research in the country relies heavily on funding from U.S. institutions, but this support has declined following decisions made by the Trump administration in early 2025. Reporting from Cape Town highlights the challenges faced by both affected communities and scientific institutions as they struggle under the weight of the disease and reduced financial support.

Stile giornalisticoFattuale
Primarily factual reporting on public health issues and research funding.





